Jean-Pascal Machiels Selected Research

Jean-Pascal Machiels Research Topics

Disease

54	Neoplasms (Cancer) 03/2024 - 10/2002
34	Squamous Cell Carcinoma of Head and Neck 03/2024 - 03/2009
20	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 11/2008
18	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2004
13	Neoplasm Metastasis (Metastasis) 12/2018 - 01/2004
10	Renal Cell Carcinoma (Grawitz Tumor) 06/2019 - 05/2008
7	Febrile Neutropenia 03/2024 - 10/2010
7	Rectal Neoplasms (Rectal Cancer) 09/2015 - 03/2006
6	Fatigue 01/2022 - 05/2015
5	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 05/2010
5	Carcinoma (Carcinomatosis) 11/2019 - 12/2006
4	Exanthema (Rash) 01/2022 - 05/2008
3	Pneumonia (Pneumonitis) 03/2024 - 04/2011
3	Pain (Aches) 01/2023 - 08/2005
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2021 - 08/2005
3	Retinoblastoma (Glioblastoma, Retinal) 03/2021 - 01/2019
3	Ovarian Neoplasms (Ovarian Cancer) 08/2010 - 07/2003
2	Deglutition Disorders (Dysphagia) 03/2024 - 04/2011
2	Stomatitis 03/2024 - 10/2019
2	Sepsis (Septicemia) 03/2024 - 10/2013
2	Carcinogenesis 01/2022 - 01/2016
2	Edema (Dropsy) 10/2020 - 01/2013
2	Neutropenia 04/2020 - 10/2010
2	Hyperglycemia 01/2020 - 10/2016
2	Hypothyroidism 12/2019 - 06/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 12/2019 - 01/2013
2	Diarrhea 10/2019 - 05/2008
2	Asthenia 01/2017 - 05/2015
2	Melanoma (Melanoma, Malignant) 08/2013 - 08/2010
2	Inflammation (Inflammations) 08/2013 - 06/2009
2	Amenorrhea 01/2013 - 02/2008
2	Ovarian Epithelial Carcinoma 01/2010 - 07/2003

Drug/Important Bio-Agent (IBA)

17	Docetaxel (Taxotere)FDA Link 12/2019 - 02/2008
15	Cetuximab (Erbitux)FDA Link 03/2021 - 01/2008
13	ErbB Receptors (EGF Receptor)IBA 03/2021 - 05/2008
11	Monoclonal AntibodiesIBA 01/2022 - 09/2010
9	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2008
9	PlatinumIBA 12/2019 - 07/2003
7	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2020
7	LigandsIBA 03/2023 - 05/2010
6	pembrolizumabIBA 03/2024 - 01/2019
6	Methotrexate (Mexate)FDA LinkGeneric 12/2019 - 04/2011
5	Hormones (Hormone)IBA 10/2010 - 02/2008
4	NivolumabIBA 12/2023 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 11/2014
4	taxaneIBA 01/2023 - 10/2010
4	Phosphotransferases (Kinase)IBA 01/2022 - 05/2008
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2019 - 05/2011
4	Tyrosine Kinase InhibitorsIBA 06/2019 - 02/2012
4	KetorolacIBA 01/2019 - 06/2010
4	Abiraterone AcetateIBA 01/2017 - 01/2016
4	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 07/2011
4	Fluorouracil (Carac)FDA LinkGeneric 12/2016 - 02/2008
4	cabazitaxel FDA Link 12/2016 - 10/2010
4	Prednisone (Sone)FDA LinkGeneric 01/2013 - 11/2008
3	AfatinibIBA 05/2023 - 10/2015
3	Retinoblastoma ProteinIBA 03/2021 - 01/2019
3	Cyclin-Dependent Kinase 4IBA 03/2021 - 01/2019
3	ribociclibIBA 03/2021 - 01/2019
3	Sunitinib (Sutent)FDA Link 06/2019 - 12/2012
3	dactolisibIBA 01/2017 - 09/2016
3	Trastuzumab (Herceptin)FDA Link 01/2015 - 12/2009
3	human ERBB2 proteinIBA 12/2012 - 05/2008
3	Capecitabine (Xeloda)FDA Link 06/2009 - 01/2004
2	Circulating Tumor DNAIBA 03/2024 - 10/2021
2	AntigensIBA 02/2024 - 10/2002
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023 - 12/2019
2	talazoparibIBA 01/2023 - 10/2022
2	VaccinesIBA 12/2022 - 11/2021
2	emactuzumabIBA 01/2022 - 10/2020
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2020
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2020 - 11/2010
2	tisotumab vedotinIBA 01/2020 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 08/2012
2	Messenger RNA (mRNA)IBA 10/2017 - 05/2011
2	NVP-BKM120IBA 01/2017 - 01/2017
2	TOR Serine-Threonine KinasesIBA 10/2016 - 09/2016
2	Everolimus FDA Link 10/2016 - 02/2012
2	Angiogenesis InhibitorsIBA 01/2016 - 08/2011
2	Analgesics (Analgesic Drugs)IBA 05/2015 - 06/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 05/2011
2	Gemcitabine FDA Link 01/2015 - 01/2013
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2013 - 10/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 02/2008
2	Epirubicin (Ellence)FDA LinkGeneric 01/2012 - 02/2008
2	CytokinesIBA 02/2011 - 05/2008

Therapy/Procedure

34	Therapeutics 03/2024 - 05/2008
19	Drug Therapy (Chemotherapy) 01/2023 - 07/2003
14	Castration 02/2024 - 10/2010
12	Radiotherapy 11/2018 - 01/2008
4	Chemoradiotherapy 03/2024 - 03/2006
3	Combined Modality Therapy 06/2020 - 05/2012
3	Palliative Care (Palliative Therapy) 10/2013 - 06/2007
3	Neoadjuvant Therapy 05/2011 - 07/2003
2	Duration of Therapy 10/2022 - 10/2016
2	Immunotherapy 11/2021 - 01/2016
2	Aftercare (After-Treatment) 01/2020 - 10/2010
2	Neck Dissection (Radical Neck Dissection) 03/2012 - 03/2009
2	Molecular Targeted Therapy 08/2011 - 05/2011